Inovio Pharmaceuticals (INO) Operating Leases (2019 - 2026)
Inovio Pharmaceuticals (INO) reported Operating Leases of $5.1 million for Q2 2026, down 36.2% from $8 million a year earlier and down 11.8% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Inovio Pharmaceuticals posted Operating Leases of $6.55 million, down 30.1% from FY2024.
- Operating Leases has declined for six consecutive years, with a five-year compound annual growth rate of -18.4% (FY2020 to FY2025).
- By year, Operating Leases came in at $9.37 million in FY2024 (-15.1%), $11.03 million in FY2023 (-12.8%), $12.66 million in FY2022 (-18.1%) and $15.46 million in FY2021 (-14.4%).
- The Q2 2026 figure ranks as the lowest quarterly Operating Leases in data going back to Q1 2019.
- Year over year, Operating Leases has now declined in each of the last 26 quarters, with an average decline of 25.1% over the last eight quarters.
- Across the past five years, year-over-year decline in Operating Leases ran from 7.5% in Q1 2024 to 36.2% in Q2 2026.
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.79 million (Q1 2026), $6.55 million (Q4 2025) and $7.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Inovio Pharmaceuticals | 99.58 Mn | 99.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.10 Mn |
| Mar 31, 2026 | 5.79 Mn |
| Dec 31, 2025 | 6.55 Mn |
| Sep 30, 2025 | 7.28 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 8.70 Mn |
| Dec 31, 2024 | 9.37 Mn |
| Sep 30, 2024 | 10.02 Mn |
| Jun 30, 2024 | 10.66 Mn |
| Mar 31, 2024 | 11.27 Mn |
| Dec 31, 2023 | 11.03 Mn |
| Sep 30, 2023 | 11.19 Mn |
| Jun 30, 2023 | 11.70 Mn |
| Mar 31, 2023 | 12.19 Mn |
| Dec 31, 2022 | 12.66 Mn |
| Sep 30, 2022 | 13.31 Mn |
| Jun 30, 2022 | 14.05 Mn |
| Mar 31, 2022 | 14.77 Mn |
| Dec 31, 2021 | 15.46 Mn |
| Sep 30, 2021 | 16.13 Mn |
API Access
Inovio Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();